Uspehi Molekularnoj Onkologii : Impact Factor & More
eISSN: 2413-3787pISSN: 2313-805X
Open AccessShare this on:
Key Metrics
CiteScore 
0.2
H-Index
2
SJR
Q4Cancer Research
SNIP
0.09
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Uspehi Molekularnoj Onkologii
Uspehi Molekularnoj Onkologii Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | ABC-press Publishing House |
| Language | Russian |
| Publication Time | 8 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Russian |
| Society/Institute/Sponsor | N.N. Blokhin Russian Cancer Research Center |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Uspehi Molekularnoj Onkologii ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Uspehi Molekularnoj Onkologii
Alternative signaling pathways for regulation of programmed cell death 1 protein expression in T lymphocytes
- 14 Dec 2025
- Advances in Molecular Oncology
Epstein–Barr virus and nasopharyngeal carcinoma: сurrent view at the problem. Part 1. Epstein–Barr virus and its properties
- 14 Dec 2025
- Advances in Molecular Oncology
AID/APOBEC family and its role in carcinogenesis
- 14 Dec 2025
- Advances in Molecular Oncology
Epithelial-mesenchymal transition in high grade serous ovarian cancer cells
- 14 Dec 2025
- Advances in Molecular Oncology
Regulatory T cells in the primary tumor growth lesion in colorectal cancer
- 14 Dec 2025
- Advances in Molecular Oncology
The role of disulfide isomerases in post-translational modification of NaPi2b (<i>SLC34A2</i>) in ovarian carcinoma cells
- 14 Dec 2025
- Advances in Molecular Oncology
Alternative signaling pathways for regulation of programmed cell death 1 protein expression in T lymphocytes
- 14 Dec 2025
- Advances in Molecular Oncology
Epstein–Barr virus and nasopharyngeal carcinoma: сurrent view at the problem. Part 1. Epstein–Barr virus and its properties
- 14 Dec 2025
- Advances in Molecular Oncology
AID/APOBEC family and its role in carcinogenesis
- 14 Dec 2025
- Advances in Molecular Oncology
Epithelial-mesenchymal transition in high grade serous ovarian cancer cells
- 14 Dec 2025
- Advances in Molecular Oncology
Regulatory T cells in the primary tumor growth lesion in colorectal cancer
- 14 Dec 2025
- Advances in Molecular Oncology
The role of disulfide isomerases in post-translational modification of NaPi2b (<i>SLC34A2</i>) in ovarian carcinoma cells
- 14 Dec 2025
- Advances in Molecular Oncology
FAQs on Uspehi Molekularnoj Onkologii
How many articles did Uspehi Molekularnoj Onkologii publish last year? 
What is the eISSN & pISSN for Uspehi Molekularnoj Onkologii?
What is Citescore for Uspehi Molekularnoj Onkologii?
What is the H Index for Uspehi Molekularnoj Onkologii ?
What is SNIP score for Uspehi Molekularnoj Onkologii?
What is the SJR for Uspehi Molekularnoj Onkologii?
Who is the publisher of Uspehi Molekularnoj Onkologii?
